A NEW non-invasive urine test that uses the protein Keratin 17 (K17) as a biomarker to detect new or recurrent bladder cancer may be a breakthrough in determining the early causes of bladder cancer.

A faster, cheaper and more reliable test to detect bladder cancer has been developed, US scientists have said. The test, which provides results within an hour, checks for a protein in urine which ...

Researchers have identified 10 genetic mutations that can predict the most common type of bladder cancer up to 12 years prior to diagnosis. The study results were presented at the European Association ...

March 10, 2023: A collaboration between University of Birmingham researchers and liquid biopsy cancer detection and screening company Nonacus, has resulted in a novel test for the non-invasive ...

A new urine test could help detect bladder cancer before symptoms start, according to a recent study. Bladder cancer is the tenth most common cancer worldwide and the fourth most prevalent among men.

Nonacus is aiming to launch the 'highly sensitive' non-invasive bladder cancer test within 12 months Genetic testing company Nonacus has partnered with the University of Birmingham to develop a ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

The ‘YORKSURe’ trial is investigating whether urine self-testing kits and community early detection clinics are an effective way of screening for bladder health problems including bladder cancer. The ...

Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being ...

The deal gives clinicians in PathNet's national lab network access to Valar's AI-powered Vesta diagnostic portfolio for non-muscle invasive bladder cancer.

While the current approval focuses on the second-line setting, research is already moving into earlier stages of the ...